Legality · 5-MeO-DMT (Bufo / Toad)5-MeO-DMT (Bufo / Toad) in Dominica: not individually verified
Also known as: the god molecule
Not individually verified
We have not confirmed that 5-MeO-DMT (Bufo / Toad) specifically is scheduled in Dominica, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.
- What is on record
- Not confirmed. No entry for 5-MeO-DMT was found in Part I, Part II or Part III of the Third Schedule to the Drugs (Prevention of Misuse) Act, Chapter 40:07, on a reading of the three complete printed lists as page images at the revision note «L.R.O. 1/1991» printed in the footer of those pages. This row turns on a single word in the Schedule. The Class A list prints «Buffogenine» between «Bezitramide» and «Cannabinol, except where contained in cannabis or cannabis resin»; the alphabetical position is consistent with bufotenine and the identification is not pushed further than that. 5-MeO-DMT is the methyl ether of bufotenine. Part I paragraph 3 reaches «Any ester of a substance for the time being specified in paragraph 1 or 2» and it does not add an ether, which the corresponding paragraph in the Regulations printed later in this same Chapter does. So the one route that would reach this compound is closed by the word the Act chose. The absence is bounded by that revision and by nothing further: section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, Orders of that kind are published separately, and this consolidation reproduces none made after the note its Schedule pages carry. So about thirty five years of possible additions sit outside what was read, and that gap is why this row is left open here rather than published as a finding that the substance is uncontrolled in Dominica.
Confirm directly with Dominica’s national drug authority or your own embassy before you rely on anything.
What Dominica HAS confirmed for related substances
These are related compounds, not 5-MeO-DMT (Bufo / Toad). Their status may or may not reflect 5-MeO-DMT (Bufo / Toad)’s. Confirm 5-MeO-DMT (Bufo / Toad) directly with Dominica's national drug authority or your embassy.
4-AcO-DMT is controlled in Dominica by derivation, being reached by the Third Schedule to the Drugs (Prevention of Misuse) Act, Chapter 40:07, from a printed entry rather than by a printed entry of its own. 4-AcO-DMT is not printed. It is the acetate ester of psilocin, and the psilocin entry is printed in Part I as «Pislocin», quoted exactly as the revised edition sets it. Part I paragraph 3 reaches any ester of a paragraph 1 substance, so the same derivation that reaches psilocybin reaches this compound, and it is a derivation and not a printed entry. Note what paragraph 3 does not say: it reaches an ester and, unlike the corresponding paragraph in the Regulations printed later in this Chapter, it does not add an ether. Section 4(1)(a) makes a controlled drug any substance for the time being specified in Parts I, II or III of that Schedule and section 4(1)(b) makes a Class A drug any substance specified in Part I. Paragraph 4 of Part I extends the entry to any salt of the listed substance and paragraph 5 to any preparation or other product containing it. The placement is stated as at the revision this text carries: the Third Schedule occupies printed pages 30 to 33 and those pages are authorised by the footer note «L.R.O. 1/1991». Section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, and this consolidation reproduces no Order made after that authorisation, so the placement stated here is a floor and not a closed account of the position today.
Dominica, the Drugs (Prevention of Misuse) Act, Act 20 of 1988 as amended by Act 15 of 1989 and Act 15 of 1990, revised edition Chapter 40:07, sections 4, 5, 6, 7, 27, 29 and 32 and the Third and Fourth Schedules · read from the 64 page scanned chapter held in this repository at research/instruments/dominica/dm-drugs-prevention-of-misuse-1988.pdf, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, with its text layer at dm-drugs-prevention-of-misuse-1988.txt, sha256 d47a9b795cabe1a1250ebd6ec3e13e4ccb6367708b69fded78a8eb22b7ab1465. The entry relied on for this row is «Pislocin» in Part I, read on printed page 30 or 31 as a page image rendered from the scan, because the text layer of this scan silently drops the «Part II» and «Part III» headings and one numbered paragraph in each of those Parts · the complete Class A, Class B and Class C lists were read that way and not by searching the text. The Third Schedule pages carry the footer «L.R.O. 1/1991» and the Fourth Schedule figures quoted here were read off the page images of printed pages 34 and 35. This citation is document level and not per substance: the compilation's links column for this row holds the constructed text «4-aco-dmt national source» rather than an address, and no per row source exists. The compilation read for this row recorded no printed entry claim, so nothing from it was carried across. The Part and Class placement stated for this row is not printed in the quotation column of the compilation read alongside the Act: measured across that compilation, not one of its 88 rows carries a Part, a Class or a Schedule marker of any kind, and its instrument column says only that there is a controlled-drug schedule without naming which of the four Schedules that is. Every division named in this cell is therefore taken from the printed Third Schedule pages of the Act itself. Second instrument relied on: Dominica, the Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, assented to and gazetted 30 October 2020 and passed in the House of Assembly on 26 October 2020, a four page Act read in full from the Government of Dominica laws site at https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf, sha256 c5f6a5b47cee1ffce3f88993d72163a1f0ba6a1f3cf68c31f8bfed89e1c5af01. It amends section 7(4), inserts sections 7A and 7B, amends section 8 and makes no amendment to the Third Schedule. Read as at 22 September 2026. · Verified October 8, 2026
DMT is a Class A controlled drug under the Drugs (Prevention of Misuse) Act, Chapter 40:07. Part I of the Third Schedule prints the entry «N, N-Dimethyltryptamine». The Act prints the chemical name with a space after the first comma, in the block of chemically named entries at the foot of the Part I column, and prints «N, N-Diethyltrptamine» separately a few lines above it, with the letters of tryptamine transposed in the revised edition's own setting. Section 4(1)(a) makes a controlled drug any substance for the time being specified in Parts I, II or III of that Schedule and section 4(1)(b) makes a Class A drug any substance specified in Part I. Paragraph 4 of Part I extends the entry to any salt of the listed substance and paragraph 5 to any preparation or other product containing it. The placement is stated as at the revision this text carries: the Third Schedule occupies printed pages 30 to 33 and those pages are authorised by the footer note «L.R.O. 1/1991». Section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, and this consolidation reproduces no Order made after that authorisation, so the placement stated here is a floor and not a closed account of the position today. The compilation recorded «DIMETILTRIPTAMINA (DMT)» as the printed entry for this row. That string does not appear anywhere in this Act; the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act.
Dominica, the Drugs (Prevention of Misuse) Act, Act 20 of 1988 as amended by Act 15 of 1989 and Act 15 of 1990, revised edition Chapter 40:07, sections 4, 5, 6, 7, 27, 29 and 32 and the Third and Fourth Schedules · read from the 64 page scanned chapter held in this repository at research/instruments/dominica/dm-drugs-prevention-of-misuse-1988.pdf, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, with its text layer at dm-drugs-prevention-of-misuse-1988.txt, sha256 d47a9b795cabe1a1250ebd6ec3e13e4ccb6367708b69fded78a8eb22b7ab1465. The entry relied on for this row is «N, N-Dimethyltryptamine» in Part I, read on printed page 30 or 31 as a page image rendered from the scan, because the text layer of this scan silently drops the «Part II» and «Part III» headings and one numbered paragraph in each of those Parts · the complete Class A, Class B and Class C lists were read that way and not by searching the text. The Third Schedule pages carry the footer «L.R.O. 1/1991» and the Fourth Schedule figures quoted here were read off the page images of printed pages 34 and 35. This citation is document level and not per substance: the compilation's links column for this row holds the constructed text «dmt national source» rather than an address, and no per row source exists. The compilation recorded «DIMETILTRIPTAMINA (DMT)» as the printed entry for this row. That string does not appear anywhere in this Act · the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act. The Part and Class placement stated for this row is not printed in the quotation column of the compilation read alongside the Act: measured across that compilation, not one of its 88 rows carries a Part, a Class or a Schedule marker of any kind, and its instrument column says only that there is a controlled-drug schedule without naming which of the four Schedules that is. Every division named in this cell is therefore taken from the printed Third Schedule pages of the Act itself. Second instrument relied on: Dominica, the Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, assented to and gazetted 30 October 2020 and passed in the House of Assembly on 26 October 2020, a four page Act read in full from the Government of Dominica laws site at https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf, sha256 c5f6a5b47cee1ffce3f88993d72163a1f0ba6a1f3cf68c31f8bfed89e1c5af01. It amends section 7(4), inserts sections 7A and 7B, amends section 8 and makes no amendment to the Third Schedule. Read as at 22 September 2026. · Verified September 21, 2026
Psilocybin is controlled in Dominica by derivation, being reached by the Third Schedule to the Drugs (Prevention of Misuse) Act, Chapter 40:07, from a printed entry rather than by a printed entry of its own. Psilocybin is not printed in Parts I to III under that name or any other. What is printed, in the second Part I column between «concentrate of poppy-straw» and «Racemethorphan», is «Pislocin», quoted exactly as the revised edition sets it and read as psilocin; the printer's transposition is in the printed page, as the page image shows. Psilocybin is the phosphate ester of psilocin, and Part I paragraph 3 reaches any ester of a substance specified in paragraph 1. That is a derivation and not a printed entry: it imports a chemical premise about the relationship between the two compounds which the Act itself does not state. Section 4(1)(a) makes a controlled drug any substance for the time being specified in Parts I, II or III of that Schedule and section 4(1)(b) makes a Class A drug any substance specified in Part I. Paragraph 4 of Part I extends the entry to any salt of the listed substance and paragraph 5 to any preparation or other product containing it. The placement is stated as at the revision this text carries: the Third Schedule occupies printed pages 30 to 33 and those pages are authorised by the footer note «L.R.O. 1/1991». Section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, and this consolidation reproduces no Order made after that authorisation, so the placement stated here is a floor and not a closed account of the position today. The string «PSILOCIBINA» does not appear anywhere in this Act, which is written in English.
Dominica, the Drugs (Prevention of Misuse) Act, Act 20 of 1988 as amended by Act 15 of 1989 and Act 15 of 1990, revised edition Chapter 40:07, sections 4, 5, 6, 7, 27, 29 and 32 and the Third and Fourth Schedules · read from the 64 page scanned chapter held in this repository at research/instruments/dominica/dm-drugs-prevention-of-misuse-1988.pdf, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, with its text layer at dm-drugs-prevention-of-misuse-1988.txt, sha256 d47a9b795cabe1a1250ebd6ec3e13e4ccb6367708b69fded78a8eb22b7ab1465. The entry relied on for this row is «Pislocin» in Part I, read on printed page 30 or 31 as a page image rendered from the scan, because the text layer of this scan silently drops the «Part II» and «Part III» headings and one numbered paragraph in each of those Parts · the complete Class A, Class B and Class C lists were read that way and not by searching the text. The Third Schedule pages carry the footer «L.R.O. 1/1991» and the Fourth Schedule figures quoted here were read off the page images of printed pages 34 and 35. This citation is document level and not per substance: the compilation's links column for this row holds the constructed text «psilocybin national source» rather than an address, and no per row source exists. The compilation recorded «PSILOCIBINA» as the printed entry for this row. That string does not appear anywhere in this Act · the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act. The Part and Class placement stated for this row is not printed in the quotation column of the compilation read alongside the Act: measured across that compilation, not one of its 88 rows carries a Part, a Class or a Schedule marker of any kind, and its instrument column says only that there is a controlled-drug schedule without naming which of the four Schedules that is. Every division named in this cell is therefore taken from the printed Third Schedule pages of the Act itself. Second instrument relied on: Dominica, the Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, assented to and gazetted 30 October 2020 and passed in the House of Assembly on 26 October 2020, a four page Act read in full from the Government of Dominica laws site at https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf, sha256 c5f6a5b47cee1ffce3f88993d72163a1f0ba6a1f3cf68c31f8bfed89e1c5af01. It amends section 7(4), inserts sections 7A and 7B, amends section 8 and makes no amendment to the Third Schedule. Read as at 22 September 2026. · Verified October 8, 2026
This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.
